Siemens Healthineers (ETR:SHL) PT Set at €48.00 by Sanford C. Bernstein

Siemens Healthineers (ETR:SHL) received a €48.00 ($55.81) price objective from analysts at Sanford C. Bernstein in a report released on Tuesday, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the stock. Sanford C. Bernstein’s price objective would suggest a potential upside of 10.00% from the company’s previous close.

A number of other analysts also recently issued reports on the stock. Morgan Stanley set a €37.00 ($43.02) price objective on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Thursday, September 12th. Nord/LB set a €36.00 ($41.86) price objective on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Monday, July 29th. Royal Bank of Canada set a €36.00 ($41.86) price objective on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Monday, November 4th. Goldman Sachs Group set a €38.00 ($44.19) price objective on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Monday. Finally, UBS Group set a €37.00 ($43.02) price objective on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, twelve have given a hold rating and four have given a buy rating to the stock. Siemens Healthineers currently has a consensus rating of “Hold” and an average target price of €39.43 ($45.84).

ETR:SHL traded up €0.05 ($0.06) during trading hours on Tuesday, hitting €43.64 ($50.74). The stock had a trading volume of 608,116 shares. The company has a 50 day simple moving average of €37.80 and a two-hundred day simple moving average of €36.76. The company has a debt-to-equity ratio of 55.12, a current ratio of 1.30 and a quick ratio of 0.87. Siemens Healthineers has a one year low of €33.05 ($38.42) and a one year high of €43.48 ($50.55). The firm has a market capitalization of $43.59 billion and a price-to-earnings ratio of 30.54.

About Siemens Healthineers

Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.

Recommended Story: Risk Tolerance

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.